Etrasimod for ulcerative colitis when other treatments fail
Treatments studied
Part of Digestive system clinical trials.
This trial provides access to an investigational medicine called etrasimod for people with ulcerative colitis who have not been helped by at least three other treatments, or who cannot take them. It's a compassionate use program, meaning it's for patients with no other options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have ulcerative colitis.
- You must have tried at least three standard treatments for ulcerative colitis, unless you couldn't take them for medical reasons.
- Those treatments either didn't work, caused side effects you couldn't handle, or were not safe for you.
- Your doctor must be willing to request this special access for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the medicine etrasimod can help children with moderate to severe ulcerative colitis. You may still be able to join even if you are already taking other treatments for your condition.
This study watches how well etrasimod works for adults with moderate to severe ulcerative colitis (UC). You must already be prescribed etrasimod by your doctor, and the study collects information through a web-based tool.
This study tests a new combination treatment for moderate-to-severe ulcerative colitis (UC). The goal is to see if adding an investigational drug to an existing UC therapy helps reduce symptoms and improve the lining of the colon.
This trial tests new medicines for people with moderate to severe ulcerative colitis who haven't found relief with standard treatments. Participants will receive one of several investigational drugs (these are not yet approved and are being studied for safety and tolerability). The goal is to see if the drugs are safe and if they might help control symptoms.
This trial tests two different medicines, infliximab and upadacitinib, to see which works better for people with severe ulcerative colitis that hasn't improved after 3 days of IV steroids. The goal is to find the best rescue option to help you feel better and avoid surgery.
This trial tests an oral medication called etrasimod for elderly patients with active ulcerative colitis. It aims to see if the drug is safe and effective in reducing inflammation and symptoms.
Hear when a new Colitis, Ulcerative trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.